Pfizer challenges Novo and Lilly: GLP-1 drug available for pre-order in China Pfizer is strengthening its position in the rapidly growing weight-loss sector Pfizers GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of intensifying competition with rivals in a market analysis expected to be worth billions of dollars
This product is intended for laboratory research use only and is not approved for human or veterinary use
Theres so much interest, [researchers studying virtually] every disease are looking at GLP-1s, Dushay says
These medications primarily work by stimulating the release of insulin from the pancreas, which helps to lower blood sugar levels, along with other benefits like increasing fullness and decreasing hunger
Retatrutide remains an investigational compound and is not an approved medicine
Microdosing is also worth talking about with your provider if youve struggled with the GI side effects of GLP-1s especially if theyve caused you to stop taking your medication
